Andreas Halvorsen's position in BridgeBio Pharma is currently worth $995 Million. That's 2.92% of their equity portfolio (10th largest holding). The investor owns 12.56% of the outstanding BridgeBio Pharma stock. Andreas Halvorsen started to build up the position in BridgeBio Pharma in Q2 2019. Since then they sold 4.57 Million shares. The stake costed the investor $608 Million, netting the investor a gain of 64% so far.